Publications by authors named "Katell LeLay"

Claim this Profile
C
Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers.
Christos Chouaid, Laura Luciani, Katell LeLay, Pascal Do, Jaafar Bennouna

J Thorac Oncolยท October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis